Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details Textual)

v3.7.0.1
Stockholders' Equity (Details Textual) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 06, 2015
Jan. 31, 2016
Jan. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Stockholders' Equity (Textual)            
Warrants issued to purchase common stock     6,975,000      
Aggregate shares of common stock     13,950,000      
Gross proceeds from sale of shares     $ 13,950,000      
Warrants, description     Each whole warrant was exercisable to acquire one share of the Company's common stock at a price of $2.00 per share at any time up to January 6, 2017.      
Offering expenses     $ 996,516   $ 35,811  
Proceeds from issuance, net     12,953,484      
Incurred internal offering costs     $ 785,197      
Common stock, shares authorized       75,000,000 75,000,000  
Common stock, par value       $ 0.001 $ 0.001  
Preferred stock, shares authorized       5,000,000 5,000,000  
Preferred stock, par value       $ 0.001 $ 0.001  
Preferred stock, outstanding        
Conversion of of Series B Preferred into common stock 5,400,000          
Proceeds from exercise options       $ 2,600  
stock based compensation       735,429 396,850  
Research and development expense       3,606,515 1,966,221  
General and administrative expense       $ 2,470,062 $ 1,908,080  
Recognized options vest over period       4 years    
Warrant [Member]            
Stockholders' Equity (Textual)            
Warrants issued to purchase common stock   125,000   365,550 7,002,774  
Proceeds from exercise options       $ 2,969,454    
Options exercised       (1,745,890)  
Number of options cancelled        
Number of options granted       490,550 7,002,774  
Warrant exercise price per share   $ 1.15     $ 2.00  
Number of warrants exercised       1,745,890    
Warrant exercised       1,484,727    
Description of vesting rights   The Company's common stock to an investor relations firm as partial compensation for consulting services to be provided over a two-year period. The warrant is exercisable at $1.15 per share, has a term of three years and is subject to vesting over the two-year service period.        
Stock Options [Member]            
Stockholders' Equity (Textual)            
Stock option aggregate grant fair value       $ 1,418,000 $ 301,557  
Options exercised       10,000    
Number of options granted       1,696,000 388,124 127,532
Recognized options vest over period       4 years 4 years  
Class of warrant or right expiration term       10 years 10 years  
Stock Options [Member] | Maximum [Member]            
Stockholders' Equity (Textual)            
Exercise prices of stock option       $ 1.55 $ 1.17  
Stock Options [Member] | Minimum [Member]            
Stockholders' Equity (Textual)            
Exercise prices of stock option       $ 1.10 $ 1.00  
Compensation Expense [Member]            
Stockholders' Equity (Textual)            
Research and development expense       $ 374,292 $ 181,158  
General and administrative expense       361,137 215,692  
Compensation Options [Member]            
Stockholders' Equity (Textual)            
Warrants, description     Each Compensation Option is exercisable for a unit consisting of one share of common stock and one-half of one common stock purchase warrant at an exercise price of $1.00 per unit. The Compensation Options expired on July 6, 2016. Each whole warrant issuable upon exercise of Compensation Options is exercisable to acquire one share of common stock at an exercise price of $2.00 per share at any time up to January 6, 2017.      
Proceeds from exercise options       $ 731,100 $ 55,548  
Options exercised       731,100 55,548  
Number of options granted to agents     786,696      
Warrant exercise price per share         $ 2.00  
Option granted exercise price     $ 1.00      
Number of warrants exercised       731,100 55,548  
2011 Plan [Member]            
Stockholders' Equity (Textual)            
Warrants issued to purchase common stock   125,000        
Warrants, description   The Company's common stock to an investor relations firm as partial compensation for consulting services it will provide to the Company over a two year period.        
Common stock for future issuance     6,453,069 1,665,572    
Equity incetive plan, description     In accordance with the rules of the TSX Venture Exchange regarding equity incentive plans, the number of shares that can be reserved for issuance under the 2011 Plan is equal to 20% of the Company's common stock outstanding at the completion of the offering.      
Series B Preferred Stock [Member]            
Stockholders' Equity (Textual)            
Proceeds from issuance, net           $ 2,700,000
Conversion of of Series B Preferred into common stock 5,400,000         5,400,000
Preferred stock conversion, description
Each outstanding share of Series B Preferred Stock was automatically converted into one share of common stock.
          
Amendment [Member]            
Stockholders' Equity (Textual)            
Authorized to issue and sale, shares     80,000,000      
Common stock, shares authorized     75,000,000      
Common stock, par value     $ 0.001      
Preferred stock, shares authorized     5,000,000      
Preferred stock, par value     $ 0.001      
IPO [Member]            
Stockholders' Equity (Textual)            
Number of shares sold     11,250,000 2,700,000    
Proceeds from issuance, net     $ 11,250,000 $ 2,700,000    
Price per sale of unit     $ 1.00 $ 1.00    
Warrants, description     All units consist of one share of the Company's common stock and one-half of one common stock purchase warrant.      
Number of options granted to agents         786,696  
Private Placement [Member]            
Stockholders' Equity (Textual)            
Number of shares sold     2,700,000      
Proceeds from issuance, net     $ 2,700,000      
Employees [Member] | Agents [Member]            
Stockholders' Equity (Textual)            
Number of options cancelled       26,486 5,000